Foundry Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-392,496
| Closed | -$16M | – | 286 |
|
|
2024
Q3 | $16M | Sell |
392,496
-2,321
| -0.6% | -$94.9K | 0.79% | 31 |
|
|
2024
Q2 | $15.2M | Buy |
394,817
+66,098
| +20% | +$2.54M | 0.82% | 32 |
|
|
2024
Q1 | $14.1M | Buy |
328,719
+106,130
| +48% | +$4.55M | 0.75% | 37 |
|
|
2023
Q4 | $8.25M | Sell |
222,589
-27,560
| -11% | -$1.02M | 0.5% | 55 |
|
|
2023
Q3 | $9.07M | Buy |
+250,149
| New | +$9.07M | 0.56% | 48 |
|
|
2020
Q3 | – | Sell |
-207,796
| Closed | -$10.6M | – | 425 |
|
|
2020
Q2 | $10.6M | Sell |
207,796
-17,215
| -8% | -$878K | 0.52% | 62 |
|
|
2020
Q1 | $10.7M | Buy |
225,011
+840
| +0.4% | +$39.8K | 0.6% | 49 |
|
|
2019
Q4 | $13.2M | Buy |
+224,171
| New | +$13.2M | 0.5% | 66 |
|
|
2019
Q3 | – | Sell |
-268,396
| Closed | -$13.4M | – | 394 |
|
|
2019
Q2 | $13.4M | Buy |
268,396
+135,988
| +103% | +$6.8M | 0.53% | 58 |
|
|
2019
Q1 | $6.92M | Buy |
+132,408
| New | +$6.92M | 0.28% | 127 |
|
|
2018
Q2 | – | Sell |
-150,408
| Closed | -$7.35M | – | 394 |
|
|
2018
Q1 | $7.35M | Sell |
150,408
-320
| -0.2% | -$15.6K | 0.31% | 114 |
|
|
2017
Q4 | $6.68M | Sell |
150,728
-7,596
| -5% | -$337K | 0.28% | 130 |
|
|
2017
Q3 | $8.04M | Buy |
158,324
+16,652
| +12% | +$845K | 0.32% | 112 |
|
|
2017
Q2 | $7.64M | Buy |
+141,672
| New | +$7.64M | 0.31% | 115 |
|